Publication | Open Access
Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis
74
Citations
17
References
1982
Year
Proven Bacterial MeningitisDrug ResistanceAntimicrobial StewardshipCerebrospinal FluidBacterial MeningitisAntimicrobial ResistanceHealth SciencesAntimicrobial PharmacokineticsPharmacologyClinical MicrobiologySingle-dose PharmacokineticsAntibioticsPediatric PatientsPediatricsClinical InfectionMedicinePharmacokineticsPatients PathogensAnesthesiology
Single-dose pharmacokinetics of ceftriaxone were determined in 19 patients with proven bacterial meningitis. The dosage was 50 mg of ceftriaxone per kg. The plasma concentration time curve declined in a biexponential manner. The mean peak plasma concentration was 207 micrograms/ml, and the elimination half-life was 4 h. In 12 patients, multiple-dose pharmacokinetics were determined after a loading dose of 75 mg of ceftriaxone per kg, followed by 50-mg/kg doses every 8 h in 5 patients or every 12 h in 7 patients. The mean peak plasma concentration was 230 micrograms/ml after the first dose and 263 micrograms/ml after the last dose. Of 12 patients, 5 had trough values that were larger after multiple doses than after a single dose. Mean penetration of ceftriaxone into cerebrospinal fluid was 3.1%. The median cerebrospinal fluid bactericidal titer against the patients pathogens was greater than 1:1,024 and less than 1:2,048. The drug was well tolerated without adverse effects.
| Year | Citations | |
|---|---|---|
Page 1
Page 1